Vestcor Inc’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
61,647
+32,942
| +115% | +$715K | 0.04% | 407 |
|
|
2025
Q1 | $696K | Buy |
28,705
+840
| +3% | +$20.4K | 0.02% | 563 |
|
|
2024
Q4 | $582K | Sell |
27,865
-32,566
| -54% | -$680K | 0.02% | 621 |
|
|
2024
Q3 | $1.2M | Buy |
60,431
+9,379
| +18% | +$186K | 0.04% | 424 |
|
|
2024
Q2 | $791K | Buy |
51,052
+25,121
| +97% | +$389K | 0.03% | 497 |
|
|
2024
Q1 | $413K | Sell |
25,931
-32,937
| -56% | -$525K | 0.01% | 719 |
|
|
2023
Q4 | $990K | Sell |
58,868
-747
| -1% | -$12.6K | 0.03% | 447 |
|
|
2023
Q3 | $697K | Buy |
59,615
+7,942
| +15% | +$92.9K | 0.03% | 518 |
|
|
2023
Q2 | $694K | Buy |
51,673
+6,759
| +15% | +$90.8K | 0.03% | 523 |
|
|
2023
Q1 | $745K | Hold |
44,914
| – | – | 0.03% | 526 |
|
|
2022
Q4 | $835K | Buy |
44,914
+9,887
| +28% | +$184K | 0.03% | 517 |
|
|
2022
Q3 | $449K | Hold |
35,027
| – | – | 0.02% | 705 |
|
|
2022
Q2 | $246K | Buy |
+35,027
| New | +$246K | 0.01% | 857 |
|